Deep Track Capital, LP 13D and 13G filings for 4D Molecular Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:13 am Purchase | 2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital, LP | 4,096,452 7.880% | 1,812,080 (+79.33%) | Filing |
| 2024-02-14 08:43 am Sale | 2023-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital, LP | 2,284,372 5.340% | -372,529 (-14.02%) | Filing |
| 2023-02-14 08:32 am Purchase | 2022-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital, LP | 2,656,901 8.200% | 756,901 (+39.84%) | Filing |
| 2022-02-14 08:56 am Purchase | 2021-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital, LP | 1,900,000 5.910% | 100,000 (+5.56%) | Filing |
| 2021-11-04 5:02 pm Purchase | 2021-10-29 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital, LP | 1,800,000 5.690% | 1,800,000 (New Position) | Filing |